For a succinct analysis of 1H 2024 venture investment and exit activity in life sciences and health care, take a look at HSBC’s Venture Healthcare Report, Shake it off: HSBC Innovation Banking Analysis, 1H 2024. Lead author Jonathan Norris and his team analyze early stage, venture deals, private M&A and IPO activity in Healthtech, Med Device, Biopharma, and Dx/Tools, in both the United States and Europe. The Report also provides a deep dive into growth and investment in computational biology.
Several key findings of the Report are:
- 1H 2024 investments in Healthtech reversed the 2023 decline with deal activity rising each quarter. The sector also experienced a surge in earlier-stage deals.
- Med device investments are reported to remain stable in large part to an increase in first-financing deals and dollars in 2Q 2024. An increase in early-stage investments in deals requiring robust clinical trials, particularly in neurology.
- For Biopharma, the Report highlights exists and a strong M&A market for growth in the sector. Investment in Biopharma reportedly increased by 35%, and there were 51 private deals exceeding $100 million.
- Dx/Tools sector experienced a decline in first-financing deals. A resurgence of growth investors for companies reaching commercialization provided a bright spot for this sector. Early-stage valuations are reported to remain strong but companies with “lofty” valuations from 2020-2021 experienced down or flat rounds.
The Report summarizes that 1H 2024 experienced increased investment across every analyzed sector with numerous investor-led financings. IPO interest increased in Biopharma as well as high deal-value private M&A.
Author(s)
Related Insights
October 22, 2026
Foley Career Perspectives
Foley’s 2026 Senior Counsel Leadership Development Program Impacts Professional Growth, Relationships, and Engagement
Leadership development is an ongoing process of learning, reflection, and practical application. That progression was at the heart of Foley’s 2026 Senior Counsel Leadership Development Program, which brought together 20 senior counsel for a months-long experience designed to strengthen their leadership capabilities and prepare them for long-term success within the firm.
October 21, 2026
Foley Viewpoints
The $2,500 Question: What Employers Need to Know About Contributing to Trump Accounts
Trump accounts are not just a matter for families; they also give employers a new tax-advantaged benefit to offer to employees. The OBBBA created “Trump accounts,” or tax-advantaged savings accounts for children, and a companion tax break that lets employers contribute up to $2,500 per employee each year to the accounts of employees and their dependents.
October 21, 2026
Foley Viewpoints
No More Counting Zeros: IRS Proposed Rules Make Dependent Care FSA Testing Easier and May Open the Door to the $7,500 Limit
For many companies, the end of the plan year brings an unwelcome headache: the DCAP fails its nondiscrimination testing, and HCEs learn that their elections must be capped or that part of their benefit will be taxable. Newly proposed regulations provide some relief for these issues.